TMIGD2/NFAT Luciferase Reporter Jurkat Cell Line
Recombinant Jurkat cell line expressing firefly luciferase under the control of an NFAT response element, and with constitutive expression of human TMIGD2 (Transmembrane and immunoglobulin domain containing 2; CD28H; NM_144615). Expression of the firefly luciferase gene is driven by NFAT response elements located upstream of the minimal TATA promoter. Activation of the NFAT signaling pathway in these cells can be monitored by measuring luciferase activity.
Interested in screening and profiling inhibitors, blocking antibodies, or activators of TMIGD2 without the need to purchase and license the cell line? Check out our Cell Signaling Pathway Screening.
Purchase of this cell line is for research purposes only; commercial use requires a separate license. View the full terms and conditions.
Materials Required for Cell Culture
Name | Ordering Information |
Thaw Medium 2 | BPS Bioscience #60184 |
Growth Medium 2A | BPS Bioscience #60190 |
Materials Required for Cellular Assay
Name | Ordering Information |
Anti-HHLA2(B7-H7) antibody [1] | Bahatt RS, 2021 (see references) |
Growth Medium 2A | BPS Bioscience #60190 |
Assay Medium: Thaw Medium 2 | BPS Bioscience #60184 |
B7-H7(HHLA2)/TCR Activator CHO Cell Line | BPS Bioscience #78321 |
96-well tissue culture treated, white, clear-bottom assay plate | Corning #3610 |
ONE-Step™ luciferase assay system | BPS Bioscience #60690 |
Luminometer |
The cell line has been screened to confirm the absence of Mycoplasma species.
HHLA2 (B7-H7) mediates an immune-stimulatory signal via TMIGD2 in naïve T cells while it delivers an immune-inhibitory signal through KIR3DL3 (Killer Cell Immunoglobulin Like Receptor, Three Ig Domains and Long Cytoplasmic Tail 3) in activated T cells and Natural Killer (NK) cells.